Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Acrylamide Increase the Risk of Neurodegenerative and Cardiovascular Disease?

NCT06224725 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06224725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06224725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Acrylamide Increase the Risk of Neurodegenerative and Cardiovascular Disease?
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
January 1, 2004
Completion date
December 31, 2022
Enrollment
1,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, dementia alzheimers, myocardial infarction, parkinson disease